Biolife Solutions Inc (NASDAQ: BLFS) on November 20, 2023, started off the session at the price of $12.78, soaring 5.01% from the previous trading day. During the day, the shares moved up to $13.73 and dropped to $12.73 before settling in for the closing price of $12.77. Within the past 52 weeks, BLFS’s price has moved between $8.92 and $26.89.
Annual sales at Healthcare sector company grew by 75.40% over the past five years. The company achieved an average annual earnings per share of 54.41%. With a float of $42.20 million, this company’s outstanding shares have now reached $42.83 million.
Let’s look at the performance matrix of the company that is accounted for 467 employees. In terms of profitability, gross margin is +27.28, operating margin of -24.67, and the pretax margin is -89.53.
Biolife Solutions Inc (BLFS) Insider Updates
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Biolife Solutions Inc is 4.16%, while institutional ownership is 102.10%. The most recent insider transaction that took place on Nov 13, was worth 1,422. In this transaction EVP & Chief Scientific Officer of this company sold 132 shares at a rate of $10.77, taking the stock ownership to the 275,726 shares. Before that another transaction happened on Nov 13, when Company’s Chief Quality Officer sold 114 for $10.77, making the entire transaction worth $1,228. This insider now owns 125,539 shares in total.
Biolife Solutions Inc (BLFS) Performance Highlights and Predictions
As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.67 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.37) by -$0.3. This company achieved a net margin of -86.43 while generating a return on equity of -33.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.00% during the next five years compared to -74.11% drop over the previous five years of trading.
Biolife Solutions Inc (NASDAQ: BLFS) Trading Performance Indicators
Biolife Solutions Inc (BLFS) is currently performing well based on its current performance indicators. A quick ratio of 1.72 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of Biolife Solutions Inc (BLFS)
Biolife Solutions Inc (NASDAQ: BLFS) saw its 5-day average volume 0.69 million, a positive change from its year-to-date volume of 0.39 million. As of the previous 9 days, the stock’s Stochastic %D was 87.93%. Additionally, its Average True Range was 0.92.
During the past 100 days, Biolife Solutions Inc’s (BLFS) raw stochastic average was set at 30.07%, which indicates a significant decrease from 92.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.91% in the past 14 days, which was lower than the 81.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.13, while its 200-day Moving Average is $17.94. Nevertheless, the first resistance level for the watch stands at $13.85 in the near term. At $14.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.85. If the price goes on to break the first support level at $12.85, it is likely to go to the next support level at $12.29. Assuming the price breaks the second support level, the third support level stands at $11.85.
Biolife Solutions Inc (NASDAQ: BLFS) Key Stats
Market capitalization of the company is 590.44 million based on 44,031K outstanding shares. Right now, sales total 161,760 K and income totals -139,810 K. The company made 33,330 K in profit during its latest quarter, and -29,130 K in sales during its previous quarter.